Oxidative and energetic stresses mediate beta-cell dysfunction induced by PGC-1α.

Area of Science:

• Endocrinology
• Metabolic research
• Mitochondrial biology

Background:

• Adverse fetal events, specifically high glucocorticoid (GC) levels, can program altered functional beta-cell mass in adults.
• GCs inhibit beta-cell development by stimulating peroxisome proliferator-activated receptor-gamma coactivator 1-alpha (PGC-1α) expression, which impairs beta-cell mass and function when overexpressed.

Purpose of the Study:

• To investigate how PGC-1α affects mitochondrial function in beta cells.
• To determine the role of PGC-1α in regulating insulin secretion.

Main Methods:

• Studied beta-cell function in mice with beta-cell-specific PGC-1α overexpression.
• Utilized MIN6 cells overexpressing PGC-1α in vitro.

Main Results:

• In vivo, PGC-1α overexpression reduced beta-cell mass during early fetal life.
• In vitro, PGC-1α stimulated mitochondrial biogenesis and respiration but not ATP production, increasing oxidative stress and impairing glucose-stimulated insulin secretion.
• Oxidative stress and subsequent AMPK activation in PGC-1α-overexpressing beta cells were identified as key disruptors of insulin secretion, with blocking these pathways restoring secretion.

Conclusions:

• PGC-1α induces oxidative stress in beta cells, leading to impaired insulin secretion through AMPK activation.
• Managing oxidative and energetic stress in beta cells presents a potential therapeutic strategy to restore insulin secretion.